DCDC Health Services Pvt Ltd, a leading operator of dialysis clinics under the brand DCDC Kidney Care, has raised ₹82 crore from British International Investment (BII), the UK’s development finance institution and impact investor. The funding aims to enhance access to critical, life-saving dialysis treatments for economically weaker sections, particularly those suffering from end-stage renal disease (ESRD).
The company plans to leverage this investment to expand its presence in South India, with a focus on Karnataka and Telangana. “We are excited to partner with BII and expand access to high-quality and affordable dialysis treatments. Through this investment we will continue to expand our centres in South India, particularly in Karnataka and Telangana,” said Aseem Garg, Founder and CEO, DCDC.
DCDC operates its dialysis clinics under a public-private partnership (PPP) model in collaboration with state governments. This model enables the company to deliver affordable treatments to low-income patients. With the new funding, the company intends to grow its network to over 100 centres and deploy over 900 dialysis machines in the next three years.
BII’s debt facility will play a pivotal role in this expansion, ensuring access to life-saving treatments in remote towns. “Improving inclusion for economically disadvantaged groups, including access to quality, affordable healthcare, is a key priority for BII in India. Our debt facility will enable DCDC to expand its network of centres in partnership with the government, which provides life-saving treatment to low-income people in remote towns,” said Srini Nagarajan, Managing Director and Head of Asia for BII.
Currently, DCDC operates over 190 clinics across India and provides treatment to over 15,000 unique patients, primarily from low-income backgrounds. The expansion is also expected to create 1,000 direct jobs, further boosting healthcare accessibility and employment opportunities.